3-D Sys Corp Del Stock Price, News & Analysis

3D Systems (NYSE: DDD) has launched VSP® Hybrid Guides, a groundbreaking solution for maxillofacial surgeons combining titanium's strength with nylon's softness, enhancing surgical precision. Developed from customer feedback, these patient-specific guides offer improved visibility and confidence during procedures. The guides are designed for easy connection and can accommodate multiple cutting locations, saving time in the operating room. Currently in a limited launch, they're expected to be widely available by May 2021, marking a significant advancement in personalized surgical solutions.

3D Systems (DDD) announced its financial results for Q1 2021 will be available after market close on May 10, 2021. A conference call and webcast for discussing these results is scheduled for May 11, 2021, at 8:30 a.m. Eastern Time. Investors can listen via the company’s investor website or participate through a dedicated telephone line. The company has provided standard forward-looking statements cautioning about risks and uncertainties that may affect future results and performance.

3D Systems (NYSE: DDD) announced a collaboration with Huntington Ingalls Industries’ Newport News Shipbuilding to develop Copper-Nickel (CuNi) and Nickel-Copper (NiCu) alloys for additive manufacturing. These new marine alloys aim to replace traditional casting methods, potentially reducing lead times by up to 75% and enhancing supply chain efficiency. The materials, known for their corrosion resistance and durability, will enable the production of complex parts traditionally made through lengthy casting processes. Successful development could expand 3D Systems' materials portfolio for various applications.

3D Systems announced a delay in filing its Annual Report on Form 10-K due to cash flow presentation issues related to the divestiture of its Cimatron and GibbsCam software businesses. Despite this, the company reported a Q4 2020 revenue of $172.7 million, a 2.6% increase from Q4 2019, driven by a 48% growth in its Healthcare segment. Overall FY 2020 revenue was $557.2 million, down 12.4% from 2019 due to COVID-19 impacts. The company anticipates gross profit margins between 40% and 44% for 2021, with improved liquidity and cost savings initiatives enhancing future prospects.

3D Systems (NYSE:DDD) has launched its High Speed Fusion (HSF) industrial 3D printer platform, developed in collaboration with Jabil Inc. The new Roadrunner printer promises printing speeds three times faster than standard systems while achieving high precision. With capabilities for high-temperature materials, the marketplace for these solutions is valued at over $400 million. This innovation aims to cater to demanding sectors like aerospace and automotive, addressing previous limitations of high production costs and low throughput.

3D Systems (DDD) has delayed its fourth quarter and full year 2020 conference call, now set for March 2, 2021, after filing financial results on March 1, 2021. The company reaffirmed preliminary revenue expectations for Q4 2020 between $170M to $176M, and a GAAP operating loss ranging from $(8.6)M to $0.5M. Notably, the company may report internal control deficiencies, potentially indicating material weaknesses in its fiscal 2020 Annual Report.

3D Systems (NYSE: DDD) has been selected by Raytheon Technologies and the U.S. Army Research Laboratory to assist in a project aimed at optimizing additively manufactured parts for military applications. This innovative research will focus on improving heat transfer and overall system performance using 3D Systems' DMP Factory 500 metal 3D printing solution. The initiative aims to enhance the Army's modernization efforts by integrating advanced technologies in design, monitoring, and data security.

3D Systems (NYSE: DDD) is increasing its investment in regenerative medicine and bioprinting, driven by advancements with United Therapeutics. The collaboration aims to create 3D-printed lung scaffolds with vascularization to support living cells. Significant technology improvements enable broad applications in regenerative medicine, reducing reliance on animal testing for drug development. The company plans to expand resources in R&D and enhance its partner network, focusing on innovative applications that meet critical healthcare needs.

3D Systems (NYSE: DDD) announced the completion of the sale of its Cimatron and GibbsCAM software businesses for approximately $64 million, using part of the proceeds to repay its senior secured term loan, eliminating debt. The company reported strong preliminary Q4 2020 revenues expected between $170 million and $176 million, with over 20% organic growth in both Healthcare and Industrial units. Non-GAAP operating income is projected at $11-$19 million, significantly improving from Q4 2019. The firm will release detailed Q4 results on February 24, 2021.